AuNP Pyrazolo[3,4-


Journal

ACS medicinal chemistry letters
ISSN: 1948-5875
Titre abrégé: ACS Med Chem Lett
Pays: United States
ID NLM: 101521073

Informations de publication

Date de publication:
14 May 2020
Historique:
received: 20 11 2019
accepted: 05 03 2020
entrez: 22 5 2020
pubmed: 22 5 2020
medline: 22 5 2020
Statut: epublish

Résumé

Gold-nanoparticle (AuNP)-conjugated drugs represent a promising and innovative antitumor therapeutic approach. In our study, we describe the design, the synthesis, the preparation, and the characterization of AuNPs conjugated with the pyrazolo[3,4-

Identifiants

pubmed: 32435368
doi: 10.1021/acsmedchemlett.9b00538
pmc: PMC7236040
doi:

Types de publication

Journal Article

Langues

eng

Pagination

664-670

Informations de copyright

Copyright © 2020 American Chemical Society.

Déclaration de conflit d'intérêts

The authors declare no competing financial interest.

Références

J Neurooncol. 2015 Feb;121(3):557-63
pubmed: 25411098
Mol Aspects Med. 2000 Dec;21(6):167-223
pubmed: 11173079
J Am Chem Soc. 2007 Sep 19;129(37):11653-61
pubmed: 17718495
Cancers (Basel). 2015 Mar 25;7(2):538-55
pubmed: 25815458
J Am Chem Soc. 2008 Dec 3;130(48):16130-1
pubmed: 18989963
Bioorg Med Chem Lett. 2011 Oct 1;21(19):5928-33
pubmed: 21856155
J Med Chem. 2013 Jul 11;56(13):5382-94
pubmed: 23746084
J Neurooncol. 2015 Aug;124(1):13-22
pubmed: 25981803
Cancer Lett. 2010 Dec 8;298(2):139-49
pubmed: 20947248
J Cell Biochem. 2015 May;116(5):856-63
pubmed: 25521525
N Engl J Med. 2008 Jul 31;359(5):492-507
pubmed: 18669428
Front Pharmacol. 2018 Sep 13;9:879
pubmed: 30271342
Drug Metab Dispos. 2000 Apr;28(4):423-33
pubmed: 10725311
Nano Lett. 2008 Dec;8(12):4593-6
pubmed: 19367807
N Engl J Med. 2005 Mar 10;352(10):987-96
pubmed: 15758009
J Med Chem. 2015 Jan 8;58(1):347-61
pubmed: 25469771
BMC Cancer. 2010 Nov 04;10:602
pubmed: 21050441
Materials (Basel). 2018 May 11;11(5):
pubmed: 29751640
Oncogene. 2000 Nov 20;19(49):5636-42
pubmed: 11114744
PLoS One. 2013 Apr 30;8(4):e62425
pubmed: 23638079
Spectrochim Acta A Mol Biomol Spectrosc. 2005 Oct;61(13-14):2861-6
pubmed: 16165025
Cancer Res. 2013 Jan 1;73(1):319-30
pubmed: 23074284
Front Pharmacol. 2017 Mar 31;8:166
pubmed: 28408882
Eur J Med Chem. 2009 Mar;44(3):990-1000
pubmed: 18722033
Clin Cancer Res. 2010 Dec 15;16(24):6139-49
pubmed: 20876255
Appl Radiat Isot. 2009 Jul;67(7-8 Suppl):S25-6
pubmed: 19375927
Nanomedicine. 2018 Feb 20;14(4):1137-1148
pubmed: 29471172
Mol Cancer Ther. 2016 Jul;15(7):1535-44
pubmed: 27196762
Genes Dev. 2007 Nov 1;21(21):2683-710
pubmed: 17974913
J Phys Chem B. 2006 Aug 17;110(32):15700-7
pubmed: 16898714
Chem Rev. 2004 Jan;104(1):293-346
pubmed: 14719978
Nanotechnology. 2008 Jul 23;19(29):295104
pubmed: 21730596
Small. 2005 Mar;1(3):325-7
pubmed: 17193451
Expert Opin Investig Drugs. 2010 Aug;19(8):931-45
pubmed: 20557276
J Med Chem. 2017 Jul 27;60(14):6305-6320
pubmed: 28650650
Small. 2014 Dec 29;10(24):5137-50
pubmed: 25104165

Auteurs

Alessio Molinari (A)

Dipartimento Biotecnologie, Chimica e Farmacia, Università degli Studi di Siena, Via A. Moro 2, 53100 Siena, Italy.

Giulia Iovenitti (G)

Dipartimento Biotecnologie, Chimica e Farmacia, Università degli Studi di Siena, Via A. Moro 2, 53100 Siena, Italy.

Arianna Mancini (A)

Dipartimento Biotecnologie, Chimica e Farmacia, Università degli Studi di Siena, Via A. Moro 2, 53100 Siena, Italy.
Dipartimento di Farmacia, Università di Pisa, Via Bonanno Pisano 12, 56126 Pisa, Italy.

Giovanni Luca Gravina (GL)

Dipartimento di Scienze Cliniche Applicate e Biotecnologiche, Università dell'Aquila, Via Vetoio, 67100 Aquila, Coppito, Italy.

Monia Chebbi (M)

Dipartimento Biotecnologie, Chimica e Farmacia, Università degli Studi di Siena, Via A. Moro 2, 53100 Siena, Italy.
Faculty of Sciences, Laboratory of Physical Chemistry of Condensed Materials, University of Tunis El Manar, 2092 Tunis, Tunisia.

Maura Caruana (M)

Dipartimento Biotecnologie, Chimica e Farmacia, Università degli Studi di Siena, Via A. Moro 2, 53100 Siena, Italy.

Giulia Vignaroli (G)

Dipartimento Biotecnologie, Chimica e Farmacia, Università degli Studi di Siena, Via A. Moro 2, 53100 Siena, Italy.

Francesco Orofino (F)

Dipartimento Biotecnologie, Chimica e Farmacia, Università degli Studi di Siena, Via A. Moro 2, 53100 Siena, Italy.

Enrico Rango (E)

Dipartimento Biotecnologie, Chimica e Farmacia, Università degli Studi di Siena, Via A. Moro 2, 53100 Siena, Italy.

Adriano Angelucci (A)

Dipartimento di Scienze Cliniche Applicate e Biotecnologiche, Università dell'Aquila, Via Vetoio, 67100 Aquila, Coppito, Italy.

Elena Dreassi (E)

Dipartimento Biotecnologie, Chimica e Farmacia, Università degli Studi di Siena, Via A. Moro 2, 53100 Siena, Italy.

Silvia Schenone (S)

Dipartimento di Scienze Farmaceutiche, Università degli Studi di Genova, Viale Benedetto XV 3, 16132 Genova, Italy.

Maurizio Botta (M)

Dipartimento Biotecnologie, Chimica e Farmacia, Università degli Studi di Siena, Via A. Moro 2, 53100 Siena, Italy.
Lead Discovery Siena S.r.l., Via Vittorio Alfieri 31, Castelnuovo Berardenga, 53019 Siena, Italy.
Sbarro Institute for Cancer Research and Molecular Medicine, Center for Biotechnology, College of Science and Technology, Temple University, Biolife Science Building, Suite 333, 1900 North 12th Street, Philadelphia, Pennsylvania 19122, United States.

Classifications MeSH